Response to Comments on Maddaloni et al. Osteoprotegerin, Osteopontin, and Osteocalcin Are Associated With Cardiovascular Events in Type 2 Diabetes: Insights From EXSCEL. Diabetes Care 2025;48:235-242.
Publication
, Journal Article
Maddaloni, E; Nguyen, M; Shah, SH; Holman, RR
Published in: Diabetes Care
April 1, 2025
Duke Scholars
Published In
Diabetes Care
DOI
EISSN
1935-5548
Publication Date
April 1, 2025
Volume
48
Issue
4
Start / End Page
e61 / e62
Location
United States
Related Subject Headings
- Endocrinology & Metabolism
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Maddaloni, E., Nguyen, M., Shah, S. H., & Holman, R. R. (2025). Response to Comments on Maddaloni et al. Osteoprotegerin, Osteopontin, and Osteocalcin Are Associated With Cardiovascular Events in Type 2 Diabetes: Insights From EXSCEL. Diabetes Care 2025;48:235-242. Diabetes Care, 48(4), e61–e62. https://doi.org/10.2337/dci24-0109
Maddaloni, Ernesto, Maggie Nguyen, Svati H. Shah, and Rury R. Holman. “Response to Comments on Maddaloni et al. Osteoprotegerin, Osteopontin, and Osteocalcin Are Associated With Cardiovascular Events in Type 2 Diabetes: Insights From EXSCEL. Diabetes Care 2025;48:235-242.” Diabetes Care 48, no. 4 (April 1, 2025): e61–62. https://doi.org/10.2337/dci24-0109.
Maddaloni E, Nguyen M, Shah SH, Holman RR. Response to Comments on Maddaloni et al. Osteoprotegerin, Osteopontin, and Osteocalcin Are Associated With Cardiovascular Events in Type 2 Diabetes: Insights From EXSCEL. Diabetes Care 2025;48:235-242. Diabetes Care. 2025 Apr 1;48(4):e61–2.
Maddaloni, Ernesto, et al. “Response to Comments on Maddaloni et al. Osteoprotegerin, Osteopontin, and Osteocalcin Are Associated With Cardiovascular Events in Type 2 Diabetes: Insights From EXSCEL. Diabetes Care 2025;48:235-242.” Diabetes Care, vol. 48, no. 4, Apr. 2025, pp. e61–62. Pubmed, doi:10.2337/dci24-0109.
Maddaloni E, Nguyen M, Shah SH, Holman RR. Response to Comments on Maddaloni et al. Osteoprotegerin, Osteopontin, and Osteocalcin Are Associated With Cardiovascular Events in Type 2 Diabetes: Insights From EXSCEL. Diabetes Care 2025;48:235-242. Diabetes Care. 2025 Apr 1;48(4):e61–e62.
Published In
Diabetes Care
DOI
EISSN
1935-5548
Publication Date
April 1, 2025
Volume
48
Issue
4
Start / End Page
e61 / e62
Location
United States
Related Subject Headings
- Endocrinology & Metabolism
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences